State Of New Jersey Common Pension Fund D Seagen Inc. Transaction History

State Of New Jersey Common Pension Fund D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $720,652 - $813,410	-3,763 Reduced 4.49%	80,004 $17 Million
Q4 2022 Feb 01, 2023	BUY	$117.37 - $139.17 $153,519 - $182,034	1,308 Added 1.59%	83,767 $10.8 Million
Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $116,970 - $192,779	1,075 Added 1.32%	82,459 $14.6 Million
Q3 2021 Oct 27, 2021	SELL	$142.45 - $169.82 $10,826 - $12,906	-76 Reduced 0.09%	81,384 $13.8 Million
Q2 2021 Jul 23, 2021	BUY	$135.08 - $161.1 $492,096 - $586,887	3,643 Added 4.68%	81,460 $12.9 Million

Q1 2021 Apr 27, 2021	SELL	$137.51 - $190.8 $91,581 - $127,072	-666 Reduced 0.85%	77,817 $10.8 Million
Q4 2020 Feb 03, 2021	BUY	$164.63 - $211.93 $12.9 Million - $16.6 Million	78,483 New	78,483 $13.7 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.